Silence Therapeutics Newsroom

Chardan Capital Maintains Silence Therapeutics(SLN.US) With Buy Rating, Maintains Target Price $55

Futu NewsDec 10 21:31

Silence Therapeutics Is Maintained at Buy by Chardan Capital

Dow JonesDec 10 20:48

H.C. Wainwright Maintains Silence Therapeutics(SLN.US) With Buy Rating, Maintains Target Price $75

Futu NewsDec 10 00:32

Analysts Offer Insights on Healthcare Companies: Stoke Therapeutics (STOK) and Silence Therapeutics (SLN)

TipRanksDec 10 00:24

Silence Therapeutics Price Target Maintained With a $75.00/Share by HC Wainwright & Co.

Dow JonesDec 9 23:37

Morgan Stanley Maintains Silence Therapeutics(SLN.US) With Buy Rating, Maintains Target Price $49

Futu NewsDec 9 23:31

BMO Capital Maintains Silence Therapeutics(SLN.US) With Buy Rating, Maintains Target Price $67

Futu NewsDec 2 21:31

Silence Therapeutics: Anticipated Zerlasiran Partnership and Favorable Pelacarsen CVOT Outlook Drive Buy Rating

TipRanksDec 2 20:48

Silence Therapeutics Analyst Ratings

BenzingaNov 20 17:48

H.C. Wainwright Maintains Silence Therapeutics(SLN.US) With Buy Rating, Maintains Target Price $75

Futu NewsNov 20 01:31

Morgan Stanley Maintains Silence Therapeutics(SLN.US) With Buy Rating, Maintains Target Price $49

Futu NewsNov 19 16:41

Morgan Stanley Maintains Silence Therapeutics(SLN.US) With Buy Rating, Maintains Target Price $49

Futu NewsNov 19 16:37

Chardan Capital Maintains Silence Therapeutics(SLN.US) With Buy Rating, Maintains Target Price $55

Futu NewsNov 19 16:36

H.C. Wainwright Maintains Silence Therapeutics(SLN.US) With Buy Rating, Maintains Target Price $75

Futu NewsNov 16 00:31

Promising RNAi Developments Boost Silence Therapeutics' Buy Rating

TipRanksNov 16 00:00

Morgan Stanley Maintains Silence Therapeutics(SLN.US) With Buy Rating, Maintains Target Price $49

Futu NewsNov 15 21:33

Morgan Stanley Maintains Silence Therapeutics(SLN.US) With Buy Rating, Maintains Target Price $49

Futu NewsNov 15 18:34

Chardan Capital Maintains Silence Therapeutics(SLN.US) With Buy Rating, Maintains Target Price $55

Futu NewsNov 15 04:31

Morgan Stanley Maintains Silence Therapeutics(SLN.US) With Buy Rating, Maintains Target Price $49

Futu NewsNov 6 20:31

Buy Rating for Silence Therapeutics: Promising Phase 1 Results and Future Prospects

TipRanksNov 6 20:11